The Role of Molecular Conformation on Tumor Uptake of Polymeric Contrast Agents
- 1 March 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 39 (3) , 131-137
- https://doi.org/10.1097/01.rli.0000107495.48025.97
Abstract
We wanted to test the hypothesis that linear extended polymers are able to translocate across compromised endothelia to a much higher degree than polymers that are in a coiled configuration. The basis for this hypothesis is the concept of polymer reptation, a process allowing linear polymers to move around fixed obstacles and through small pores. The conjugation of polylysine with DTPA was varied from 55% to 95% of lysine moieties for a fixed polymer degree of polymerization. The variable conjugation constructs were assessed in their ability to enhance tumor signals in an animal model. The blood circulation time was also assessed, as was the proton relaxivity of the constructs. The relaxivity values of the variable conjugation constructs indicated that the conformation of the highly conjugated polymers was consistent with an extended conformation. Images of the highly conjugated constructs with cryoelectron microscopy showed structures also consistent with an extended peptide chain conformation. These constructs gave tumor signal enhancements 10 times larger than observed for constructs of lower conjugation at the same injection dose. The conformation of polymer agents is of decisive importance in the imaging efficacy of tumors. Polylysine conjugates of Gd-DTPA, at conjugation levels of 90% or higher, assume an extended linear conformation, which enables them to translocate across tumor endothelium more effectively than less highly conjugated polymers.Keywords
This publication has 32 references indexed in Scilit:
- Characteristics of a New MRI Contrast Agent Prepared From Polypropyleneimine Dendrimers, Generation 2Investigative Radiology, 2003
- Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance ImagingInvestigative Radiology, 2002
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingNature Medicine, 1998
- Tumor imaging with a macromolecular paramagnetic contrast agent: Gadopentetate dimeglumine-polylysineAcademic Radiology, 1995
- Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agentsMagnetic Resonance in Medicine, 1994
- Monocrystalline iron oxide nanocompounds (MION): Physicochemical propertiesMagnetic Resonance in Medicine, 1993
- In Vivo and In Vitro Evaluation of Gd-DTPA-Polylysine as a Macromolecular Contrast Agent for Magnetic Resonance ImagingInvestigative Radiology, 1991
- Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.Radiology, 1990
- Albumin Labeled with Gd-DTPAInvestigative Radiology, 1987